U.S, February 24, 2020 (CANNABISTECH) Unbiased scientific research means looking for benefits, as well as risks.
Cannabidiol (CBD) has been highly touted and heavily hyped. Its medicinal qualities are perceived as limitless by some, and its non-psychoactive nature makes it suitable for just...
U.S, August 7, 2019 (MARIJUANA BUSINESS DAILY)- It’s no secret that the number of business relationships between American and Canadian cannabis interests has skyrocketed since federal legalization went into effect north of the U.S. border.
From a high-level perspective, it’s a simple trade: money for market access. That’s particularly true...
U.S, May 6, 2020 (GREENMARKETREPORT) New March 2020 point-of-sale data from BDS Analytics shows a divergence between states where cannabis sales are improving during the COVID-19 lockdown versus states whose business has declined. According to the data, California sales have experienced another month of double-digit growth, following a troublesome...
U.S, March 27, 2020 (CANABISTECH) Cannabis manufacturers and investors are turning their eyes toward South America, where opportunities for future profits abound. Quest-for-low-cost-cannabis-shines-a-spotlight-on-south-america
South America features an ideal confluence of factors that promise a great financial harvest for the medical cannabis industry....
U.S, April 6, 2020 (ANALYTICALCANNABIS) The number of American adolescents who vape cannabis or use cannabis edibles has increased in recent years, while the number smoking cannabis has declined, say the authors of a new research letter published in JAMA Pediatrics.
The accessibility of...
Announcement comes less than 24 hours after staff members revealed they had been asked to resign.
US press secretary Jen Psaki has confirmed that five people have lost their jobs at the White House after admitting to past cannabis use.
So far, 14 states and the...
U.S, March 19, 2020 (HEMPGAZETTE) Early this week, Americans For Safe Access sent a letter to governors and directors of state medical cannabis programs across the USA requesting immediate action be taken to ensure medical cannabis access is maintained during the COVID-19 crisis.
UNITED STATES, August 28, 2019 (HEMP INDUSTRY DAILY) - A Kentucky company planning to develop hemp-derived wood products has begun production even as it appeals a 25% tariff on some equipment from China.
Fibonacci opened its $5.8 million facility in Murray, Kentucky, this week.
The company, which plans to employ 25 people...
U.S, April 17, 2020 (MARIJUANABUSINESSDAILY) Marijuana retail businesses in markets that depend on travelers and tourism for at least a portion of their sales are being forced to pivot in response to the coronavirus pandemic in part by appealing more to local customers.
Stay-at-home...
U.S, February 21, 2020 (HEMPGAZETTE) It’s looking like Thunderbirds are go for a medical cannabis insomnia product developed by Zelira Therapeutics (ASX:ZLD).
In case you’re wondering who Zelira is, you might recognise it by its previous name – Zelda Therapeutics. The name change came...









